Little pill means big news in the treatment of multiple sclerosis
Tuesday, January 26, 2010 - 00:21
in Health & Medicine
A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers. A major trial of the oral drug Cladribine has shown that it significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.